CareDx (STU:1K9) ROE % Adjusted to Book Value : 32.59% (As of Dec. 2024)

View and export this data going back to 2017. Start your Free Trial

What is CareDx ROE % Adjusted to Book Value?

CareDx's ROE % for the quarter that ended in Dec. 2024 was 98.09%. CareDx's PB Ratio for the quarter that ended in Dec. 2024 was 3.01. CareDx's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2024 was 32.59%.

CareDx ROE % Adjusted to Book Value Historical Data

The historical data trend for CareDx's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CareDx ROE % Adjusted to Book Value Chart

CareDx Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

-0.76

-1.73

-12.71

-21.86

5.55

CareDx Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
ROE % Adjusted to Book Value	Get a 7-Day Free Trial															-57.60	-12.17	-0.75	-1.91	32.59

Competitive Comparison of CareDx's ROE % Adjusted to Book Value

For the Diagnostics & Research subindustry, CareDx's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

CareDx's ROE % Adjusted to Book Value Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, CareDx's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where CareDx's ROE % Adjusted to Book Value falls into.

CareDx ROE % Adjusted to Book Value Calculation

CareDx's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	16.70%	/	3.01
	=	5.55%

CareDx's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	98.09%	/	3.01
	=	32.59%

CareDx ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of CareDx's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

CareDx Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » CareDx Inc (STU:1K9) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

CDNA:USA

Address

8000 Marina Boulevard, Brisbane, CA, USA, 94005

Website

https://www.caredx.com

CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre-and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates major revenue from the Testing services.

CareDx Headlines

No Headlines